Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of lower extremity deep venous thrombosis after gynecologic pelvic surgery
ChiCTR-IPR-15007324Phase 4Recruiting
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Nov 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of low molecular weight heparin calcium in deep vein thrombosis (DVT) (4 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: Color Doppler ultrasound of the lower extremity vein. Started Nov 2015; status: recruiting.
02
Drugs
low molecular weight heparin calcium
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on ChiCTR-IPR-15007324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007324.